Noradrenaline Sans Sulfites Viatris (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Noradrenaline Sans Sulfites Viatris, is an adrenergic agonist presented as an injection solution for intravenous use. It treats acute hypotension, septic shock, cardiac arrest and post‑cardiac surgery low output syndrome in hospital settings under close medical supervision and intensive care units.

GNH USA supplies Noradrenaline Sans Sulfites Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide with rigorous quality assurance and reliable logistics for critical care medicines.

Noradrenaline is a vasopressor that acts on the adrenergic system to restore blood pressure in critical care settings. - Acute hypotension: raises systemic vascular resistance to increase arterial pressure. - Septic shock: improves organ perfusion by vasoconstriction and enhanced cardiac output. - Cardiac arrest: provides circulatory support during resuscitation efforts. - Post‑cardiac surgery low output syndrome: augments cardiac output and systemic pressure.

Noradrenaline may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Tachycardia: increased heart rate. - Headache: transient cranial pain. - Nausea: mild gastrointestinal upset. - Peripheral ischemia: reduced blood flow to extremities causing discomfort.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening rhythm disturbances. - Myocardial ischemia: reduced oxygen supply to heart muscle. - Severe hypertension: abrupt excessive rise in blood pressure. - Tissue necrosis at infusion site: local tissue death due to extravasation.

When using Noradrenaline, careful clinical monitoring and adherence to handling guidelines are essential. - Cardiovascular monitoring: continuous blood pressure and heart rate assessment. - Dose titration: adjust infusion rate to achieve target MAP while avoiding excessive hypertension. - Contraindications: avoid in patients with known hypersensitivity to noradrenaline or sulfite‑containing products. - Drug interactions: monitor closely when combined with beta‑blockers or MAO inhibitors. - Extravasation risk: stop infusion immediately if signs of infiltration appear and manage according to protocol. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline can interact with several medicines, influencing its pressor effect or safety profile.

Major Interactions (Avoid): - MAO inhibitors: may cause hypertensive crisis. - Tricyclic antidepressants: potentiate vasoconstriction and raise blood pressure. - Ergot alkaloids: increase risk of severe vasospasm.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt tachycardia response. - Calcium channel blockers: additive effects on blood pressure. - Diuretics: may alter intravascular volume and affect response. - Vasodilators: may reduce efficacy of noradrenaline.